NCT02191969

Brief Summary

This study will see if patient who undergo a physical activity intervention called Walk With Ease report experiencing less fatigue and a higher quality of life during chemotherapy for colorectal cancer than those who do not participate in this intervention.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
36

participants targeted

Target at below P25 for not_applicable colorectal-cancer

Timeline
Completed

Started Jun 2014

Longer than P75 for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2014

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

June 17, 2014

Completed
29 days until next milestone

First Posted

Study publicly available on registry

July 16, 2014

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 18, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 18, 2019

Completed
Last Updated

May 1, 2020

Status Verified

November 1, 2019

Enrollment Period

5.3 years

First QC Date

June 17, 2014

Last Update Submit

April 29, 2020

Conditions

Keywords

ChemotherapyAdjuvant ChemotherapyCancer TherapyFatiguePhysical ActivityPhysical FunctionTirednessColon CancerRectal CancerWalk With EaseColorectal CancerGeriatric AssessmentGeriatricElderly

Outcome Measures

Primary Outcomes (1)

  • To measure the change in fatigue after three months between the intervention and control arm

    The investigators will compare the change in fatigue from baseline to 3 months between Intervention and Control arms as measured via PROMIS®-Fatigue.

    Three Months

Secondary Outcomes (9)

  • To measure changes in physical function at baseline between the intervention and control groups.

    4 to 24 weeks

  • To measure adherence to the physical activity intervention

    One Year

  • To measure the difference in p16INK4a levels before and after chemotherapy in the control and intervention groups

    One Year

  • To measure the change in muscle mass measurements before and after chemotherapy between the intervention and control arms

    One Year

  • To measure the association of p16INK4a and muscle mass with any differences in fatigue o physical function or QOL during chemotherapy

    Six months

  • +4 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

This group will be receiving adjuvant chemotherapy for colorectal cancer. They will not participate in the Walk With Ease program. They will be followed up using standard of care.

Intervention

EXPERIMENTAL

This group will be receiving adjuvant chemotherapy for colorectal cancer. They will participate in the Walk With Ease (WWE) program during the course of their chemotherapy treatment. They will be requested to initiate the WWE starting on Day 1 of adjuvant chemotherapy. Participants are asked to walk at a safe and comfortable pace, increasing their minutes per day at a rate they can sustain, with the ultimate goal of 30 minutes/day for at least 5 days/week. They are asked to maintain a daily walking log that is provided to them, entering total minutes per day. Participants will be asked to do the walking program independently (self-directed, not in a formal group with an instructor) throughout chemotherapy.

Behavioral: Walk With Ease

Interventions

Walk With EaseBEHAVIORAL

A self-directed walking intervention developed by the Arthritis Foundation. The intervention is a workbook that coaches participants through walking regularly at a safe, comfortable pace with the ultimate goal of walking at least 30 minutes a day five days a week.

Also known as: WWE
Intervention

Eligibility Criteria

Age60 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ Age 60 years (no upper age limit)
  • Diagnosis of stage II-III colon or rectal cancer planned for treatment with adjuvant chemotherapy scheduled as part of standard treatment
  • Able to read English (required for CGA and other surveys administered)
  • Approval from their treating physician to engage in moderate-intensity physical activity
  • Patient-assessed ability to walk and engage in moderate physical activity
  • Signed, IRB-approved written informed consent

You may not qualify if:

  • Other active, invasive malignancy requiring ongoing therapy or expected to require systemic therapy
  • Already walking or engaging in other physical activity \>120 minutes per week as documented via subject self-report
  • Unable to walk or engage in moderate-intensity physical activity
  • One or more significant medical conditions that in the physician's judgment preclude participation in the walking intervention

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599, United States

Location

Related Publications (1)

  • Williams GR, Nyrop KA, Deal AM, Muss HB, Sanoff HK. Self-directed physical activity intervention in older adults undergoing adjuvant chemotherapy for colorectal cancer: Design of a randomized controlled trial. Contemp Clin Trials. 2015 May;42:90-7. doi: 10.1016/j.cct.2015.03.008. Epub 2015 Mar 28.

Related Links

MeSH Terms

Conditions

Colorectal NeoplasmsFatigueMotor ActivityColonic NeoplasmsRectal Neoplasms

Interventions

Walkingmethyl hydroxyethyl cellulose

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

LocomotionMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExerciseMotor Activity

Study Officials

  • Hy Muss, MD

    UNC Lineberger Comprehensive Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2014

First Posted

July 16, 2014

Study Start

June 1, 2014

Primary Completion

September 18, 2019

Study Completion

September 18, 2019

Last Updated

May 1, 2020

Record last verified: 2019-11

Locations